A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

December 30, 2027

Conditions
Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

99mTc-4BOH SPECT myocardial perfusion imaging

Participants undergo myocardial perfusion imaging using the investigational radiotracer 99mTc-4BOH with SPECT. Imaging is performed according to a standardized protocol. Each participant receives both this SPECT imaging and a PET imaging procedure using 13N-ammonia, in a randomized sequence, within a 7-day interval.

DIAGNOSTIC_TEST

13N-ammonia PET myocardial perfusion imaging

Participants undergo myocardial perfusion imaging using 13N-ammonia with PET as the active comparator. This procedure is performed according to standard clinical protocols. Each participant also receives 99mTc-4BOH SPECT imaging in a randomized sequence, with both tests completed within a 7-day window.

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT06980194 - A Head-to-Head Comparison of A New Perfusion Tracer, 99mTc-4BOH vs. 13N-NH3 to Evaluate Diagnostic Efficacy of Ischemic Heart Disease | Biotech Hunter | Biotech Hunter